Moderna Ramps Down MRNA Drug Substance Production For Its Covid-19 Vaccine At Lonza; Will Ramp Down Production Of MRNA Drug Substance For Its Covid-19 Vaccine At Lonza’s Site In Visp, Switzerland, In Q3 2023
Moderna Ramps Down MRNA Drug Substance Production For Its Covid-19 Vaccine At Lonza; Will Ramp Down Production Of MRNA Drug Substance For Its Covid-19 Vaccine At Lonza’s Site In Visp, Switzerland, In Q3 2023